BioIVT provides isolated peripheral blood mononuclear cells (PBMCs) from normal donors, which can be delivered fresh within 24 hours to specific locations or cryopreserved with demographic ...

Scopio Labs, a trailblazer in Full-Field Digital Cell Morphology, today announced another significant milestone: its fourth U.S. Food and Drug Administration (FDA) clearance (K243144). This latest ...

Peripheral blood stem cell transplants are safer and easier for the donor and with contemporary graft-vs-host disease (GVHD) prophylaxis, they don't appear to pose any additional GVHD risk for the ...

Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation ...

Posttransplant cyclophosphamide-based graft-vs-host disease (GVHD) prophylaxis enabled high 1-year overall survival in patients receiving peripheral blood stem cell (PBSC) transplants from human ...

An alternative diagnostic method could improve early detection and treatment of peripheral artery disease (PAD), according to a new study from the University of Surrey.

Oct. 11, 2024 — Researchers have developed a new method to recreate a robust and functional human immune system in mice using mononuclear cells from the cord blood. This new kind of mice, that ...

Patients within racial and ethnic marginalized groups (hereafter referred to as underrepresented) are far less likely than non-Hispanic White patients to identify HLA-matched donors in worldwide donor ...